Our findings indicating that C5a/C5aR1 signaling in myeloid cells was involved in the lung immunopathology of COVID-19, but not in the infiltration of these cells into the lung, prompted us to hypothesize that this signaling would be involved in the local activation of these cells. This evidence concerns the gene C5 and COVID-19.